Current:Home > NewsDrugmaker Mallinckrodt may renege on $1.7 billion opioid settlement-Angel Dreamer Wealth Society D1 Reviews & Insights
Drugmaker Mallinckrodt may renege on $1.7 billion opioid settlement
View Date:2024-12-24 07:37:51
The generic drugmaker Mallinckrodt says the company's board might not make a $200 million opioid settlement payment scheduled for later this week.
In a June 5 filing with the Securities and Exchange Commission, the financially troubled firm said it faces growing questions internally and from creditors about the payout, which is part of a $1.7 billion opioid deal reached as part of a bankruptcy deal last year.
One possibility is that the company could file for a second bankruptcy, a move that could put the entire settlement at risk.
"It could be devastating," said Joseph Steinfeld, an attorney representing individuals harmed by Mallinckrodt's pain medications. "It potentially could wipe out the whole settlement."
According to Steinfeld, individual victims overall stand to lose roughly $170 million in total compensation. The rest of the money was slated to go to state and local governments to help fund drug treatment and health care programs.
The opioid crisis has killed hundreds of thousands of Americans, sparked first by prescription pain medications, then fueled by street drugs such as fentanyl and heroin.
If Mallinckrodt files a second bankruptcy, payouts would likely go first to company executives, staff and other creditors, with opioid-related claims paid out last.
"Paying board members, paying the company professionals and paying non-victims is all well and good," Steinfeld said. "But it ignores the whole fact that the persons most harmed and the reason the company is in bankruptcy is because of the damage they've done" through opioid sales.
Katherine Scarpone stood to receive a payment in compensation after the death of her son Joe, a former Marine who suffered a fatal opioid overdose eight years ago.
She described this latest legal and financial setback as "disheartening."
"First there's the victim, right, who may lose their life and then there's the bankruptcy and going through all the painful stuff of filing and then to have all that blow up it really angers me," Scarpone told NPR.
Mallinckrodt is headquartered in Ireland and has U.S. corporate offices in Missouri and New Jersey.
A company spokesperson contacted by NPR declined to comment about the matter beyond the SEC filing.
"On June 2, 2023, the board directed management and the company's advisors to continue analyzing various proposals," the firm said in its disclosure.
"There can be no assurance of the outcome of this process, including whether or not the company may make a filing in the near term or later under the U.S. bankruptcy code or analogous foreign bankruptcy or insolvency laws."
This financial maneuver by Mallinckrodt comes at a time when drugmakers, wholesalers and pharmacy chains involved in the prescription opioid crisis have agreed to pay out more than $50 billion in settlements.
Most of the firms involved in those deals are much larger and more financially stable than Mallinckrodt.
In late May, a federal appeals court approved another opioid-related bankruptcy deal valued at more than $6 billion involving Purdue Pharma, the maker of Oxycontin.
veryGood! (847)
Related
- Kim Kardashian Says She's Raising Her and Kanye West's 4 Kids By Herself
- I'm a retired Kansas grocer. Big-box dollar stores moved into town and killed my business.
- YouTube removes right-wing media company's channels after indictment alleges Russian funding
- What's the best state for electric cars? New 2024 EV index ranks all 50 states
- Only 8 monkeys remain free after more than a week outside a South Carolina compound
- Ram 1500s, Jeep Wranglers, Jeep Gladiators among 1.2 million vehicles recalled: Check car recalls here
- Judge orders change of venue in trial of man charged with killing 4 University of Idaho students
- Selena Gomez Reacts to Benny Blanco Engagement Rumors
- Judith Jamison, acclaimed Alvin Ailey American dancer and director, dead at 81
- NFL Week 2 injury report: Puka Nacua, Jordan Love top the list after Week 1
Ranking
- Powell says Fed will likely cut rates cautiously given persistent inflation pressures
- The Latest: Harris and Trump are prepping for the debate but their strategies are vastly different
- Kate Middleton Shares She's Completed Chemotherapy Treatment After Cancer Diagnosis
- Caleb Williams has forgettable NFL debut with Chicago Bears – except for the end result
- West Virginia governor-elect Morrisey to be sworn in mid-January
- Here's every Super Bowl halftime performer by year as Kendrick Lamar is tapped for 2025
- The Bachelorette’s Jenn Tran Reunites With Jonathon Johnson After Devin Strader Breakup
- Gaudreau brothers to be honored by family, friends and their grieving hockey teammates at funeral
Recommendation
-
OneTaste Founder Nicole Daedone Speaks Out on Sex Cult Allegations Against Orgasmic Meditation Company
-
Pregnant Campbell Pookie Puckett Reveals Why Maternity Fashion Isn’t So Fire
-
NFL schedule today: What to know about Jets at 49ers on Monday Night Football
-
2025 Hyundai Tucson adds comfort, safety features for babies and pet passengers
-
Appeals Court Affirms Conviction of Everglades Scientist Accused of Stealing ‘Trade Secrets’
-
Maren Morris Reveals New Career Milestone
-
House Republicans push to link government funding to a citizenship check for new voters
-
The uproar around Francis Ford Coppola's ‘Megalopolis’ movie explained